Recently, the changes of the resolution #633 by the Russian Government coordinated Russian medical device registration requirements with Eurasian regulations. It also focused to clarify the In vitro diagnostic (IVD) and MD approval methodology.
As per the Pharmaceuticals Export Promotion Council of India, Russia was amongst the fourth countries (remaining were China, South Africa and Italy) to which exports progressed above 20% in 2017-18. These four countries contributed about 9% to the country’s pharma exports.
The US Pharmacopeial Convention (USP) and Russia's medical products regulator forged a three-year memorandum of understanding (MOU) earlier this week that will focus on harmonizing major pharmacopeial requirements and promoting the use of modern laboratory standards, among other things.
During the VI Russian Congress of Patients “State and citizens in building patient-oriented health care in Russia”, which was held on November 12, 2015, Association of International Pharmaceutical Manufacturers and Russian Patients Association signed Consensus Framework of reciprocal understanding, which sets the following core ethical principles of activity: priority to patient’s interests, high standards of medical care, partnership in the health care sector in order to improve the availability and quality of medical service and overall development of healthcare system, as well as ensuring the independence of ethical standards of activities.